Affymetrix Appoints Jami Dover Nachtsheim and Nelson C. Chan to Board of Directors
March 03 2010 - 9:00AM
Business Wire
Affymetrix, Inc. (NASDAQ:AFFX) announced today that Jami Dover
Nachtsheim and Nelson C. Chan have been appointed to the board of
directors, effective March 8, 2010. The board appointed Ms.
Nachtsheim to the Compensation Committee and Mr. Chan to the Audit
Committee.
The company also announced that John A. Young will retire from
the board of directors on Affymetrix on May 14, 2010, the date of
the company’s 2010 annual meeting of stockholders, after completing
his current term.
“We thank John for his 18 years of service on the board. We
highly value his broad business experience and leadership of the
board and we wish him well in his retirement,” said Stephen P.A.
Fodor, PhD, founder and executive chairman of Affymetrix. “We are
very pleased to add Jami Dover Nachtsheim and Nelson Chan to our
board of directors. Their business backgrounds and experiences as
public company directors will enable them to make immediate
contributions to our business and marketing strategies.”
Jami Dover Nachtsheim held a variety of positions with Intel
Corporation from 1980 until her retirement in 2000, most recently
as Corporate Vice President of the Sales and Marketing Group and
Director of Worldwide Marketing. Ms. Nachtsheim currently serves on
the board of directors of Southwall Technologies, ACT Conferencing,
and the Tech Museum of Innovation.
Nelson C. Chan served as Chief Executive Officer of Magellan
Navigation, Inc. from 2006 to 2008. From 1992 to 2006, Mr. Chan
held various senior management positions with SanDisk Corporation,
most recently Executive Vice President and General Manager,
Consumer Business. Mr. Chan currently serves on the board of
directors of Silicon Labs and Synaptics, Inc.
About Affymetrix
Affymetrix technology is used by the world’s top pharmaceutical,
diagnostic, and biotechnology companies, as well as leading
academic, government, and nonprofit research institutes. More than
1,800 systems have been shipped around the world and more than
20,000 peer-reviewed papers have been published using the
technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Cleveland, Ohio, and Singapore. The
company has about 1,100 employees worldwide and maintains sales and
distribution operations across Europe and Asia. For more
information about Affymetrix, please visit the company’s website at
www.affymetrix.com.
Forward-looking statements
All statements in this press release that are not historical are
“forward-looking statements” within the meaning of Section 21E of
the Securities Exchange Act as amended, including statements
regarding Affymetrix’ “expectations,” “beliefs,” “hopes,”
“intentions,” “strategies,” or the like. Such statements are
subject to risks and uncertainties that could cause actual results
to differ materially for Affymetrix from those projected. These and
other risk factors are discussed in Affymetrix’ Form 10-K for the
year ended December 31, 2009, and other SEC reports for subsequent
quarterly periods.
Affymetrix, the Affymetrix logo, and GeneChip® are registered
trademarks of Affymetrix Inc. All other trademarks are property of
their respective owners.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024
